Address

MedImmune Ventures Inc
One MedImmune Way
Gaithersburg, MD 20878
United States

Open map


Recent investment activity

KANDO id: 3030

Corporate information

Registration country

Funding rounds

Investment preferences


Investment activity status
Not investing

Selected investments

Displaying 1 - 25 of 30
Profile Country Date Sort ascending Funding
Coferon Inc Develops orally active drugs that act like small drug molecules, can permeate cell membranes, and once inside, can assemble into larger molecules Series B
Catabasis Pharmaceuticals Inc Series A
Ambit Biosciences Inc A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. Series D
Catabasis Pharmaceuticals Inc Series A
Rib-X Pharmaceuticals Inc N/A
Virdante Pharmaceuticals Inc A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. Series A
Arginetix Inc Biopharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase. Seed
BrainCells Inc A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. Series B
VaxInnate Inc A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases. Series C
Avidia Inc Series B
Iomai Corp Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. Series C
Inotek Pharmaceuticals Corp Inotek Pharmaceuticals is a clinical-stage ophthalmic pharmaceutical company. N/A
Corridor Pharmaceuticals Inc N/A
Cellective Therapeutics Inc N/A
Sequoia Pharmaceuticals Inc Discovers and develops antiviral drugs that inhibits various forms of viruses and prevents the emergence of drug-resistant viruses. N/A
LigoCyte Pharmaceuticals Inc N/A
VaxInnate Corp N/A
Vanda Pharmaceuticals Inc Biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders. N/A
Tercica Inc A biopharmaceutical company developing new therapeutics for endocrine system disorders. N/A
Critical Therapeutics Inc Discoverer, developer and commercialize novel therapies. N/A
Elusys Therapeutics Inc Develops antibody-based therapies to treat infectious diseases. N/A
Applied Genetic Technologies Corp A gene therapy company that designs, packages and delivers therapeutic genes to treat a variety of medical illnesses using the adeno-associates virus. N/A
NeuProtect Pty Ltd N/A
NKT Therapeutics Inc N/A
Synovex Corp N/A

Current team

Former team members

Employee Company Position
Edward Mathers New Enterprise Associates Inc
Partner
From

Responsibilities: Focus areas: Healthcare, Biopharma.

Selected Products / Customers

Financials